Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

CRISPR/Cas9 Library Screens Identified Atp2a2 As an In Vivo Specific Tumor Suppressor in Myeloid Neoplasms

Ruka Shimura, Moe Tamura, Keita Yamamoto, Kohei Iida, Shuhei Asada, Emi Sugimoto, E. Christine Pietsch, Barbara A. Weir, Ramona Crescenzo, Glenn S. Cowley, Ricardo M. Attar, Ulrike Philippar, Satoshi Yamasaki, Taisei Hirouchi, Kaoru Uchimaru, Toshio Kitamura, Susumu Goyama

Blood (2024) 144 (Supplement 1): 949.

https://doi.org/10.1182/blood-2024-206816

Published: 2024

Journal Articles

Identifying the Optimal Conditioning Intensity of Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia in Complete Remission

Blood (2023) 142 (Supplement 1): 2150.

https://doi.org/10.1182/blood-2023-181621

Published: 2023

Journal Articles

HHEX promotes myeloid transformation in cooperation with mutant ASXL1

Blood (2020) 136 (14): 1670–1684.

https://doi.org/10.1182/blood.2019004613

Published: 2020

Includes: Supplemental data

Journal Articles

Homeobox Transcription Factor Hhex Promotes Myeloid Leukemia in Cooperation with Mutant ASXL1

Blood (2019) 134 (Supplement_1): 2525.

https://doi.org/10.1182/blood-2019-126663

Published: 2019

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Aggressive Natural Killer Cell Leukemia: An Advantage of Cord Blood Transplantation

Ayumi Fujimoto, MD, Fumihiro Ishida, MD PhD, Koji Izutsu, MD PhD, Satoshi Yamasaki, MD PhD, Dai Chihara, MD PhD, Junji Suzumiya, MD PhD, Tetsuo Mitsui, MD PhD, Kazuteru Ohashi, MD PhD, Hideyuki Nakazawa, MD PhD, Hikaru Kobayashi, MD PhD, Junya Kanda, MD, Takahiro Fukuda, Yoshiko Atsuta, MD PhD, Ritsuro Suzuki, MD PhD

Blood (2019) 134 (Supplement_1): 2032.

https://doi.org/10.1182/blood-2019-122049

Published: 2019

Journal Articles

Mutant ASXL1 Promotes Expansion of the Phenotypic Hematopoietic Stem Cell Compartment

Takeshi Fujino, MD, Susumu Goyama, MD PhD, Yuki Sugiura, PhD, Daichi Inoue, MD PhD, Satoshi Yamasaki, PhD, Akiko Matsumoto, Naru Sato, MD, Hironobu Morinaga, PhD, Shiori Shikata, Tomofusa Fukuyama, MD PhD, Yosuke Tanaka, PhD, Shuhei Asada, MD PhD, Tsuyoshi Fukushima, MD PhD, Hiroaki Honda, MD PhD, Emi K Nishimura, MD PhD, Tatsuhiro Shibata, MD PhD, Makoto Suematsu, MD PhD, Toshio Kitamura, MD PhD

Blood (2019) 134 (Supplement_1): 821.

https://doi.org/10.1182/blood-2019-127904

Published: 2019

Journal Articles

Risk Factors and Predictive Scoring System for Post-Transplant Lymphoproliferative Disorder after Hematopoietic Stem Cell Transplantation

Ayumi Fujimoto, MD, Nobuhiro Hiramoto, MD, Satoshi Yamasaki, MD PhD, Yoshihiro Inamoto, MD PhD, Naoyuki Uchida, MD PhD, Tetsuo Maeda, MD, Takehiko Mori, MD PhD, Yoshinobu Kanda, MD PhD, Tadakazu Kondo, MD PhD, Junji Tanaka, MD PhD, Tatsuo Ichinohe, MD PhD, Yoshiko Atsuta, MD PhD, Masao Ogata, MD PhD, Ritsuro Suzuki, MD PhD

Blood (2018) 132 (Supplement 1): 250.

https://doi.org/10.1182/blood-2018-99-110424

Published: 2018

Journal Articles

A p53-MDM2 Interaction Inhibitor, DS-5272, Inhibits the Development of MLL-Fusion Leukemia with the Assistance of Tumor Immunity

Susumu Goyama, MD PhD, Yasutaka Hayashi, XiaoXiao Liu, Shiori Shikata, Yosuke Tanaka, Tomofusa Fukuyama, MD PhD, Akiko Matsumoto, Satoshi Yamasaki, Tatsuhiro Shibata, Toshio Kitamura, MD PhD

Blood (2017) 130 (Supplement 1): 796.

https://doi.org/10.1182/blood.V130.Suppl_1.796.796

Published: 2017

Journal Articles

Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome in Lymphoma Patients Receiving Hematopoietic Cell Transplantation

Satoshi Yamasaki, MD PhD, Ritsuro Suzuki, MD, Kaoru Hatano, Kentaro Fukushima, MD PhD, Hiroatsu Iida, MD PhD, Satoko Morishima, MD, Youko Suehiro, MD, Takahiro Fukuda, MD, Naoyuki Uchida, MD PhD, Takashi Uchiyama, MD, Yoshiko Atsuta, MD PhD, Junji Suzumiya, MD PhD

Blood (2016) 128 (22): 827.

https://doi.org/10.1182/blood.V128.22.827.827

Published: 2016

Journal Articles

Comparative Analysis of Tyrosine Kinase Inhibitors-Related Pulmonary Hypertension in the Patients Treated By Imatinib, Dasatinib and Nilotinib

Mariko Minami, MD, Toshihiro Miyamoto, MD PhD, Takeshi Arita, MD PhD, Tomohiko Kamimura, MD PhD, Junichiro Yuda, MD, Yoshikane Kikushige, MD PhD, Yasuo Mori, MDPhD, Goichi Yoshimoto, MD PhD, Kenjiro Kamezaki, MD PhD, Koji Kato, MD PhD, Motoaki Shiratsuchi, MDPhD, Katsuto Takenaka, MD PhD, Hiromi Iwasaki, MDPhD, Satoshi Yamasaki, MD PhD, Tsuyoshi Muta, MD PhD, Kazuki Tanimoto, MD PhD, Ryosuke Ogawa, MD PhD, Tetsuya Eto, MD PhD, Koichi Akashi, MD PhD

Blood (2015) 126 (23): 1583.

https://doi.org/10.1182/blood.V126.23.1583.1583

Published: 2015

Journal Articles

Comparable Leukemia-Free Survival after Autologous Hematopoietic Cell Transplantation Versus HLA-Identical Sibling Hematopoietic Cell Transplantation for Adult Acute Myeloid Leukemia in First Complete Remission: A Registry Study By the Adult AML Working Group of the Japan Society for Hematopoietic Cell Transplantation

Motonori Mizutani, MD, Masahiko Hara, Hiroyuki Fujita, Jun Aoki, Heiwa Kanamori, Shinichiro Machida, Satoshi Yamasaki, MD PhD, Kazuteru Ohashi, MD PhD, Kensuke Usuki, MDPhD, Takahiro Fukuda, MD, Takaaki Chou, Junji Tanaka, MD PhD, Yoshiko Atsuta, MDPhD, Akiyoshi Takami, MD PhD

Blood (2014) 124 (21): 2514.

https://doi.org/10.1182/blood.V124.21.2514.2514

Published: 2014

Journal Articles

Cyclophosphamide Related Cardiac Complication in Hematopoietic Transplantation: Analysis of 1091 Cases in Fukuoka Blood and Marrow Transplantation Group

Kentaro Kohno, MD, Ken Takase, MD, Masanori Kadowaki, MD, Satoshi Yamasaki, MD PhD, Tomohiko Kamimura, MD PhD, Yuju Ohno, MD, Tetsuya Eto, MD PhD, Toshihiro Miyamoto, MD PhD, Seiichi Okamura, MD PhD, Koichi Akashi, MD PhD

Blood (2014) 124 (21): 1139.

https://doi.org/10.1182/blood.V124.21.1139.1139

Published: 2014

Journal Articles

Pre-Engraftment Serum C-Reactive Protein (CRP) Value as a Predictor of Acute Graft-Versus-Host Disease and Non-Relapse Mortality.

Shigeo Fuji, MD, Sung-Won Kim, MD, Takahiro Fukuda, MD, Shin-ichiro Mori, MD, Satoshi Yamasaki, MD, Yuriko Morita-Hoshi, MD, Fusako Ohara-Waki, MD, Yuji Heike, MD, Kensei Tobinai, MD, Ryuji Tanosaki, MD, Yoichi Takaue, MD

Blood (2007) 110 (11): 1968.

https://doi.org/10.1182/blood.V110.11.1968.1968

Published: 2007

Journal Articles

Fever Following Bortezomib Administration Correlated with Serum Cytokine Levels in Patients with Multiple Myeloma (MM).

Dai Maruyama, MD, Takashi Watanabe, MD, Fusako Ohara, MD, Kazuki Tanimoto, MD, Sung-Won Kim, MD, Satoshi Yamasaki, MD, Yuriko Morita, MD, Yukio Kobayashi, MD, Kensei Tobinai, MD

Blood (2006) 108 (11): 5092.

https://doi.org/10.1182/blood.V108.11.5092.5092

Published: 2006

Journal Articles

Age-Related Risk of Non-Relapse Mortality Associated with Acute Graft-Versus-Host Disease.

Takahiro Fukuda, Yukiko Iisaka, Fusako Ohara, Atsushi Fujieda, Satoshi Yamasaki, Sung-Won Kim, Shin-ichiro Mori, Ryuji Tanosaki, Yuji Heike, Atsushi Makimoto, Kensei Tobinai, Yoichi Takaue

Blood (2006) 108 (11): 40.

https://doi.org/10.1182/blood.V108.11.40.40

Published: 2006

Journal Articles

Impact of Hepatic Toxicities on Survival after Allogeneic Hematopoietic Cell Transplantation (HCT): Comparison of Reduced-Intensity Versus Conventional Conditioning Regimens at a Single Center.

Atsushi Fujieda, Takahiro Fukuda, Fusako Ohara, Satoshi Yamasaki, Sungwon Kim, Shin-ichiro Mori, Ryuji Tanosaki, Yuji Heike, Atsushi Makimoto, Kensei Tobinai, Yoichi Takaue

Blood (2006) 108 (11): 2976.

https://doi.org/10.1182/blood.V108.11.2976.2976

Published: 2006

Journal Articles

Comparison of Outcomes after Reduced-Intensity Versus Myeloablative Stem Cell Transplantation in 128 Patients with Acute Myeloid Leukemia: A Single-Center Analysis.

Fusako Ohara, Takahiro Fukuda, Ruri Kato, Satoshi Yamasaki, Sung-Won Kim, Shin-ichiro Mori, Ryuji Tanosaki, Yuji Heike, Atsushi Makimoto, Kensei Tobinai, Yoichi Takaue

Blood (2006) 108 (11): 3023.

https://doi.org/10.1182/blood.V108.11.3023.3023

Published: 2006

Journal Articles

Allogeneic Hematopoietic Cell Transplantation for the Treatment of Hematologic Malignancies Not in Remission: The Anti-Tumor Effect of Reduced-Intensity Conditioning Is Comparable to That of Conventional Myeloablative Conditioning.

Dai Maruyama, MD, Takahiro Fukuda, MD, Ruri Kato, MD, Satoshi Yamasaki, MD, Eiji Usui, MD, Yuriko Morita, MD, Sung-Won Kim, MD, Shin-ichiro Mori, MD, Ryuji Tanosaki, MD, Kinuko Tajima, PhD, Yuji Heike, MD, Atsushi Makimoto, MD, Kensei Tobinai, MD, Yoichi Takaue, MD

Blood (2005) 106 (11): 1142.

https://doi.org/10.1182/blood.V106.11.1142.1142

Published: 2005

Journal Articles

Graft-Versus-Tumor Effects after Allogeneic Hematopoietic Cell Transplantation for the Treatment of Hematologic Malignancies.

Eiji Usui, MD, Takahiro Fukuda, MD, Ruri Kato, MD, Satoshi Yamasaki, MD, Dai Maruyama, MD, Yuriko Morita, MD, Sung-Won Kim, MD, Shin-ichiro Mori, MD, Ryuji Tanosaki, MD, Kinuko Tajima, PhD, Yuji Heike, MD, Atsushi Makimoto, MD, Kensei Tobinai, MD, Yoichi Takaue, MD

Blood (2005) 106 (11): 2015.

https://doi.org/10.1182/blood.V106.11.2015.2015

Published: 2005

Journal Articles

Hematopoietic Cell Transplantation-Specific Comorbidity Index To Predict Non-Relapse Mortality and Survival after Allografting.

Ruri Kato, MD, Takahiro Fukuda, MD, Eiji Usui, MD, Satoshi Yamasaki, MD, Dai Maruyama, MD, Yuriko Morita, MD, Sung-Won Kim, MD, Shin-ichiro Mori, MD, Ryuji Tanosaki, MD, Kinuko Tajima, PhD, Yuji Heike, MD, Atsushi Makimoto, MD, Kensei Tobinai, MD, Yoichi Takaue, MD

Blood (2005) 106 (11): 2731.

https://doi.org/10.1182/blood.V106.11.2731.2731

Published: 2005

NARROW

CRISPR/Cas9 Library Screens Identified Atp2a2 As an In Vivo Specific Tumor Suppressor in Myeloid Neoplasms

Identifying the Optimal Conditioning Intensity of Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia in Complete Remission

HHEX promotes myeloid transformation in cooperation with mutant ASXL1

Homeobox Transcription Factor Hhex Promotes Myeloid Leukemia in Cooperation with Mutant ASXL1

Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Aggressive Natural Killer Cell Leukemia: An Advantage of Cord Blood Transplantation

Mutant ASXL1 Promotes Expansion of the Phenotypic Hematopoietic Stem Cell Compartment

Risk Factors and Predictive Scoring System for Post-Transplant Lymphoproliferative Disorder after Hematopoietic Stem Cell Transplantation

A p53-MDM2 Interaction Inhibitor, DS-5272, Inhibits the Development of MLL-Fusion Leukemia with the Assistance of Tumor Immunity

Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome in Lymphoma Patients Receiving Hematopoietic Cell Transplantation

Comparative Analysis of Tyrosine Kinase Inhibitors-Related Pulmonary Hypertension in the Patients Treated By Imatinib, Dasatinib and Nilotinib

Cyclophosphamide Related Cardiac Complication in Hematopoietic Transplantation: Analysis of 1091 Cases in Fukuoka Blood and Marrow Transplantation Group

Pre-Engraftment Serum C-Reactive Protein (CRP) Value as a Predictor of Acute Graft-Versus-Host Disease and Non-Relapse Mortality.

Fever Following Bortezomib Administration Correlated with Serum Cytokine Levels in Patients with Multiple Myeloma (MM).

Age-Related Risk of Non-Relapse Mortality Associated with Acute Graft-Versus-Host Disease.

Impact of Hepatic Toxicities on Survival after Allogeneic Hematopoietic Cell Transplantation (HCT): Comparison of Reduced-Intensity Versus Conventional Conditioning Regimens at a Single Center.

Comparison of Outcomes after Reduced-Intensity Versus Myeloablative Stem Cell Transplantation in 128 Patients with Acute Myeloid Leukemia: A Single-Center Analysis.

Allogeneic Hematopoietic Cell Transplantation for the Treatment of Hematologic Malignancies Not in Remission: The Anti-Tumor Effect of Reduced-Intensity Conditioning Is Comparable to That of Conventional Myeloablative Conditioning.

Graft-Versus-Tumor Effects after Allogeneic Hematopoietic Cell Transplantation for the Treatment of Hematologic Malignancies.

Hematopoietic Cell Transplantation-Specific Comorbidity Index To Predict Non-Relapse Mortality and Survival after Allografting.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only